Aymeric Chartier

1.3k total citations
21 papers, 976 citations indexed

About

Aymeric Chartier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Plant Science. According to data from OpenAlex, Aymeric Chartier has authored 21 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Plant Science. Recurrent topics in Aymeric Chartier's work include RNA Research and Splicing (10 papers), Genetic Neurodegenerative Diseases (5 papers) and CRISPR and Genetic Engineering (4 papers). Aymeric Chartier is often cited by papers focused on RNA Research and Splicing (10 papers), Genetic Neurodegenerative Diseases (5 papers) and CRISPR and Genetic Engineering (4 papers). Aymeric Chartier collaborates with scholars based in France, United States and Germany. Aymeric Chartier's co-authors include Martine Simonelig, Martine Astier, Michel Sémériva, Béatrice Benoit, Stéphane Zaffran, Elmar Wahle, Isabelle Busseau, Patricia Rojas‐Ríos, Stéphanie Pierson and Christian Ihling and has published in prestigious journals such as Nature Communications, The EMBO Journal and Development.

In The Last Decade

Aymeric Chartier

21 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aymeric Chartier France 16 825 232 127 104 103 21 976
Gogineni Ranganayakulu United States 7 802 1.0× 235 1.0× 73 0.6× 138 1.3× 112 1.1× 11 954
Geetanjali Chawla United States 18 1.3k 1.5× 206 0.9× 65 0.5× 38 0.4× 147 1.4× 28 1.6k
Carolina N. Perdigoto United States 12 511 0.6× 231 1.0× 68 0.5× 167 1.6× 307 3.0× 25 923
Paola N. Perrat United States 10 455 0.6× 295 1.3× 133 1.0× 56 0.5× 91 0.9× 12 853
Julie Broadus United States 7 649 0.8× 415 1.8× 118 0.9× 159 1.5× 97 0.9× 7 882
Helen Doyle United States 11 1.2k 1.4× 205 0.9× 226 1.8× 157 1.5× 104 1.0× 18 1.3k
Natalia Tulina United States 9 572 0.7× 205 0.9× 62 0.5× 128 1.2× 276 2.7× 11 880
Ingolf Reim Germany 15 709 0.9× 176 0.8× 142 1.1× 93 0.9× 103 1.0× 23 855
Theophany Eystathioy Canada 16 1.2k 1.5× 99 0.4× 60 0.5× 82 0.8× 139 1.3× 20 1.5k
Victoria Corbin United States 11 892 1.1× 259 1.1× 89 0.7× 122 1.2× 120 1.2× 13 1.0k

Countries citing papers authored by Aymeric Chartier

Since Specialization
Citations

This map shows the geographic impact of Aymeric Chartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aymeric Chartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aymeric Chartier more than expected).

Fields of papers citing papers by Aymeric Chartier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aymeric Chartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aymeric Chartier. The network helps show where Aymeric Chartier may publish in the future.

Co-authorship network of co-authors of Aymeric Chartier

This figure shows the co-authorship network connecting the top 25 collaborators of Aymeric Chartier. A scholar is included among the top collaborators of Aymeric Chartier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aymeric Chartier. Aymeric Chartier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rojas‐Ríos, Patricia, Aymeric Chartier, Julie Cremaschi, et al.. (2024). piRNAs are regulators of metabolic reprogramming in stem cells. Nature Communications. 15(1). 8405–8405. 6 indexed citations
2.
3.
Guénolé, Aude, Aymeric Chartier, Anne‐Ruxandra Carvunis, et al.. (2022). RNF219 regulates CCR4-NOT function in mRNA translation and deadenylation. Scientific Reports. 12(1). 9288–9288. 4 indexed citations
4.
Ramat, Anne, Jérémy Dufourt, Céline Garret, et al.. (2020). The PIWI protein Aubergine recruits eIF3 to activate translation in the germ plasm. Cell Research. 30(5). 421–435. 39 indexed citations
5.
Rojas‐Ríos, Patricia, Aymeric Chartier, Stéphanie Pierson, & Martine Simonelig. (2017). Aubergine and pi RNA s promote germline stem cell self‐renewal by repressing the proto‐oncogene Cbl. The EMBO Journal. 36(21). 3194–3211. 40 indexed citations
6.
Dufourt, Jérémy, Aymeric Chartier, Stéphanie Pierson, et al.. (2017). piRNAs and Aubergine cooperate with Wispy poly(A) polymerase to stabilize mRNAs in the germ plasm. Nature Communications. 8(1). 1305–1305. 53 indexed citations
7.
Chartier, Aymeric, et al.. (2016). Measurement of mRNA Poly(A) Tail Lengths in Drosophila Female Germ Cells and Germ-Line Stem Cells. Methods in molecular biology. 1463. 93–102. 5 indexed citations
8.
Rojas‐Ríos, Patricia, Aymeric Chartier, Stéphanie Pierson, et al.. (2015). Translational Control of Autophagy by Orb in the Drosophila Germline. Developmental Cell. 35(5). 622–631. 24 indexed citations
9.
Chartier, Aymeric, Pierre Klein, Stéphanie Pierson, et al.. (2015). Mitochondrial Dysfunction Reveals the Role of mRNA Poly(A) Tail Regulation in Oculopharyngeal Muscular Dystrophy Pathogenesis. PLoS Genetics. 11(3). e1005092–e1005092. 44 indexed citations
10.
Chartier, Aymeric, et al.. (2013). The CCR4 Deadenylase Acts with Nanos and Pumilio in the Fine-Tuning of Mei-P26 Expression to Promote Germline Stem Cell Self-Renewal. Stem Cell Reports. 1(5). 411–424. 66 indexed citations
11.
Chartier, Aymeric & Martine Simonelig. (2012). Animal models in therapeutic drug discovery for oculopharyngeal muscular dystrophy. Drug Discovery Today Technologies. 10(1). e103–e108. 8 indexed citations
12.
Anvar, Seyed Yahya, Peter A.C. ’t Hoen, Andrea Venema, et al.. (2011). Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skeletal Muscle. 1(1). 15–15. 37 indexed citations
13.
Barbezier, Nicolas, Aymeric Chartier, Yannick Bidet, et al.. (2011). Antiprion drugs 6‐aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Molecular Medicine. 3(1). 35–49. 33 indexed citations
14.
Zhang, Lianbing, Elisabeth Kremmer, Christian Ihling, et al.. (2010). Subunits of the Drosophila CCR4-NOT complex and their roles in mRNA deadenylation. RNA. 16(7). 1356–1370. 133 indexed citations
15.
Chartier, Aymeric, Vered Raz, Ellen Sterrenburg, et al.. (2009). Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo. Human Molecular Genetics. 18(10). 1849–1859. 42 indexed citations
16.
Chartier, Aymeric, et al.. (2007). Smac/DIABLO and Colon Cancer. Anti-Cancer Agents in Medicinal Chemistry. 7(4). 467–473. 20 indexed citations
17.
Chartier, Aymeric, Béatrice Benoit, & Martine Simonelig. (2006). A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. The EMBO Journal. 25(10). 2253–2262. 79 indexed citations
18.
Benoit, Béatrice, Géraldine Mitou, Aymeric Chartier, et al.. (2005). An Essential Cytoplasmic Function for the Nuclear Poly(A) Binding Protein, PABP2, in Poly(A) Tail Length Control and Early Development in Drosophila. Developmental Cell. 9(4). 511–522. 83 indexed citations
19.
20.
Zaffran, Stéphane, Aymeric Chartier, Peter Gallant, et al.. (1998). A Drosophila RNA helicase gene, pitchoune, is required for cell growth and proliferation and is a potential target of d-Myc. Development. 125(18). 3571–3584. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gogineni Ranganayakulu Breakdown of academic impact, for papers by Geetanjali Chawla Breakdown of academic impact, for papers by Carolina N. Perdigoto Breakdown of academic impact, for papers by Paola N. Perrat Breakdown of academic impact, for papers by Julie Broadus Breakdown of academic impact, for papers by Helen Doyle Breakdown of academic impact, for papers by Natalia Tulina Breakdown of academic impact, for papers by Ingolf Reim Breakdown of academic impact, for papers by Theophany Eystathioy Breakdown of academic impact, for papers by Victoria Corbin
Rankless by CCL
2026